|
Dr. Every is a cardiologist who has been with Frazier healthcare since 1999, became a partner in 2001 and General Partner in 2005. Dr. Every is responsible for evaluating opportunities in the medical device and biotech sectors. He was integral to the formation of SyneCor, a first-of-its-kind accelerator company backed by researchers, corporations, clinicians and a leading investment bank. He founded and was start-up CEO for MacuSight, an ocular disease therapy company that was incubated at Frazier Healthcare. Dr. Every currently serves on the boards of directors at Apneon, Inc., BaroSense, Inc., BARRx, Inc., FlowCardia, Interventional Rhythm Management, Juniper, MacuSight, PowerVision, SyneCor LLC, and Xoft Microtube. He is also an observer on the boards of Alexza Pharmaceuticals and FoviOptics, Inc. Prior to joining the Frazier Healthcare, Dr. Every was an associate professor of medicine and the director of the Cardiovascular Outcomes Research Center (CORC) at the University of Washington, where he performed multiple studies evaluating the costs and outcomes of new procedures and pharmaceutical agents. His findings have been published in more than 75 scientific articles, including The New England Journal of Medicine, JAMA and The Lancet. Dr. Every earned an M.D. from Emory University School of Medicine and a master of public health (M.P.H.) degree from the University of Washington School of Public Health, and he is board certified in internal medicine and cardiovascular medicine. | 